Fluctuation in anti-cyclic citrullinated protein antibody level predicts relapse from remission in rheumatoid arthritis: KURAMA cohort

Fluctuation in anti-cyclic citrullinated protein antibody level predicts relapse from remission in rheumatoid arthritis: KURAMA cohort

Abstract Background The positivity of anti-citrullinated protein/peptide antibodies (ACPAs) is a clinically useful diagnostic and prognostic marker in rheumatoid arthritis (RA). However, the significance of ACPA titer and its fluctuation remain unclear. This study aimed to assess the role of ACPA ti...

Full description

Bibliographic Details
Main Authors: Koichi Murata, Hiromu Ito, Motomu Hashimoto, Kosaku Murakami, Ryu Watanabe, Masao Tanaka, Wataru Yamamoto, Shuichi Matsuda
Format: Article
Language:English
Published: BMC 2020-11-01
Series:Arthritis Research & Therapy
Subjects:
Anti-citrullinated protein/peptide antibody
Biomarker
Relapse
Remission
Rheumatoid arthritis
Online Access:http://link.springer.com/article/10.1186/s13075-020-02366-x

Internet

http://link.springer.com/article/10.1186/s13075-020-02366-x

Similar Items